<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="109263">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01907464</url>
  </required_header>
  <id_info>
    <org_study_id>UF 8751</org_study_id>
    <nct_id>NCT01907464</nct_id>
  </id_info>
  <brief_title>Bone Loss in Patients With Anorexia Nervosa</brief_title>
  <official_title>Physiopathology of Bone Loss in Young Patient With Anorexia Nervosa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <authority>France: Committee for the Protection of Personnes</authority>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nutritional deprivation of adolescent girls with anorexia nervosa (AN) reduces the bone mass
      acquisition. A better understanding of this process would improve the medical treatment of
      bone alteration and its long-term consequences.

      160 patients (age &lt; 38 yr) with AN and 160 age-matched controls (CON) will be enrolled in
      this study. The areal bone mineral density (aBMD) will be determined using dual-X-ray
      absorptiometry. Calciotropic hormones, bone turnover markers will be concomitantly
      evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Dual-X-ray absorptiometry (DEXA)</measure>
    <time_frame>at Day 0 (time of the inclusion visit)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The primary outcome is to model the bone mass acquisition in young women with anorexia nervosa.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biological parameters identification</measure>
    <time_frame>At day 0 (time of the inclusion visit)</time_frame>
    <safety_issue>No</safety_issue>
    <description>One of the secondary outcome is to identify biological factors associated with bone demineralisation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>clinical parameters identification</measure>
    <time_frame>At Day 0 (at time of the the inclusion visit)</time_frame>
    <safety_issue>No</safety_issue>
    <description>One of the secondary outcome is to identify the clinical factors associated with bone demineralisation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Patients With Anorexia Nervosa</condition>
  <arm_group>
    <arm_group_label>Patients with anorexia nervosa</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm is the experimental arm composed of patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controls subjects</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm is composed of healthy volunteers</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>clinical parameters description</intervention_name>
    <description>description of weight, height, Bone Mass Index, dietary questionnary, amenorrhea time, pathology time for the two arms</description>
    <arm_group_label>Patients with anorexia nervosa</arm_group_label>
    <arm_group_label>controls subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>para clinical parameters description</intervention_name>
    <description>description of DMO, mass, basal metabolism, IGF-1/IGFBP-3 for the two arms</description>
    <arm_group_label>Patients with anorexia nervosa</arm_group_label>
    <arm_group_label>controls subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>hormonal parameters dosing</intervention_name>
    <description>dosing of leptine, leptine receptor, adiponectine, ghreline for the two arms</description>
    <arm_group_label>Patients with anorexia nervosa</arm_group_label>
    <arm_group_label>controls subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>bone modeling markers dosing</intervention_name>
    <description>dosing of osteocalcine, bone alkalin phosphatase, C-telopeptide of type-I collagene, osteoprotegerine/ RANKL for the two arms</description>
    <arm_group_label>Patients with anorexia nervosa</arm_group_label>
    <arm_group_label>controls subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed Consent

          -  Health Insurance regimen or benefit from an health insurance regimen

          -  Aged from 14 to 38 years old

          -  Women

          -  No pregnant

        Specific inclusion criteria for patient:

        Patient suffering from anorexia nervosa defined by criteria of Diagnostic and Statistical
        Manual of Mental Disorders (DSM-IV)

        Specific inclusion criteria for controls:

          -  Normal menstrual cycles,

          -  No lifetime history of eating disorders,

          -  BMI between 18 and 25 kg/m²

        Exclusion Criteria:

          -  use of treatments may be modify bone mass (bisphosphonates,…)

          -  Disease or treatment may be induce osteoporosis

          -  In exclusion period in relation with another study

          -  Law protected subject
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick PL LEFEBVRE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick PL LEFEBVRE, MD</last_name>
    <phone>+33 4 67 33 84 31</phone>
    <email>p-lefebvre@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Montpellier - Département d'Endocrinologie Diabète</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent LM MAIMOUN, PhD</last_name>
      <phone>+33 4 67 33 79 99</phone>
      <email>l-maimoun@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Patrick PL LEFEBVRE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 22, 2013</lastchanged_date>
  <firstreceived_date>July 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anorexia nervosa</keyword>
  <keyword>Bone mineral density</keyword>
  <keyword>Teenagers or young women</keyword>
  <keyword>Bone remodelling markers</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
